Should all trials have a data safety and monitoring committee?
Am Heart J
.
2001 Jan;141(1):156-63.
doi: 10.1067/mhj.2001.112501.
Authors
J A Cairns
1
,
A Hallstrom
,
P Held
Affiliation
1
University of British Columbia, Vancouver, British Columbia, Canada. jacairns@medd.med.ubc.ca
PMID:
11136502
DOI:
10.1067/mhj.2001.112501
No abstract available
MeSH terms
Clinical Trials as Topic / standards*
Data Collection / standards*
Pharmacy and Therapeutics Committee*
Safety*